Skip to main content
SpringerLink
Log in

Anthracyclines/trastuzumab

Left ventricular ejection fraction (LVEF) decline, heart failure and cardiac arrest: 24 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hussain Y, et al. Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction. Breast Cancer Research and Treatment 175: 239-246, No. 1, May 2019. Available from: URL: http://doi.org/10.1007/s10549-019-05139-6 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anthracyclines/trastuzumab. Reactions Weekly 1755, 26 (2019). https://doi.org/10.1007/s40278-019-62580-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-62580-5

Search

Navigation